{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T07:43:13Z","timestamp":1775634193465,"version":"3.50.1"},"reference-count":27,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"6","funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R56HL127995"],"award-info":[{"award-number":["R56HL127995"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Adv."],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:p>Patients with HIV have higher thrombogenicity that correlates with markers of inflammation; both respond to clopidogrel treatment.<\/jats:p>","DOI":"10.1126\/sciadv.aav5463","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T23:15:27Z","timestamp":1560381327000},"source":"Crossref","is-referenced-by-count":25,"title":["Targeting thrombogenicity and inflammation in chronic HIV infection"],"prefix":"10.1126","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4476-8057","authenticated-orcid":true,"given":"Meagan P.","family":"O\u2019Brien","sequence":"first","affiliation":[{"name":"Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6567-5194","authenticated-orcid":true,"given":"M. Urooj","family":"Zafar","sequence":"additional","affiliation":[{"name":"Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose C.","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4632-3206","authenticated-orcid":true,"given":"Ibeawuchi","family":"Okoroafor","sequence":"additional","affiliation":[{"name":"Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2407-371X","authenticated-orcid":true,"given":"Alex","family":"Heyison","sequence":"additional","affiliation":[{"name":"Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Cavanagh","sequence":"additional","affiliation":[{"name":"Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Rodriguez-Caprio","sequence":"additional","affiliation":[{"name":"Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1312-2897","authenticated-orcid":true,"given":"Alan","family":"Weinberg","sequence":"additional","affiliation":[{"name":"Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gines","family":"Escolar","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, Hospital Clinic, Barcelona, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8162-0284","authenticated-orcid":true,"given":"Judith A.","family":"Aberg","sequence":"additional","affiliation":[{"name":"Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6780-8771","authenticated-orcid":true,"given":"Juan J.","family":"Badimon","sequence":"additional","affiliation":[{"name":"Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/QAI.0000000000001450","article-title":"Increased risk of myocardial infarction in HIV-infected individuals in north america compared with the general population","volume":"75","author":"Drozd D. R.","year":"2017","unstructured":"D. R. Drozd, M. M. Kitahata, K. N. Althoff, J. Zhang, S. J. Gange, S. Napravnik, G. A. Burkholder, W. C. Mathews, M. J. Silverberg, T. R. Sterling, S. R. Heckbert, M. J. Budoff, S. van Rompaey, J. A. C. Delaney, C. Wong, W. Tong, F. J. Palella, R. A. Elion, J. N. Martin, J. T. Brooks, L. P. Jacobson, J. J. Eron, A. C. Justice, M. S. Freiberg, D. B. Klein, W. S. Post, M. S. Saag, R. D. Moore, H. M. Crane, Increased risk of myocardial infarction in HIV-infected individuals in north america compared with the general population. J. Acquir. Immune Defic. Syndr. 75, 568\u2013576 (2017).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/eurheartj\/ehq372","article-title":"Acute coronary syndrome in human immunodeficiency virus-infected patients: Characteristics and 1 year prognosis","volume":"32","author":"Boccara F.","year":"2011","unstructured":"F. Boccara, M. Mary-Krause, E. Teiger, S. Lang, P. Lim, K. Wahbi, F. Beygui, O. Milleron, P. Gabriel Steg, C. Funck-Brentano, M. Slama, P.-M. Girard, D. Costagliola, A. Cohen; Prognosis of Acute Coronary Syndrome in HIV-infected patients, Acute coronary syndrome in human immunodeficiency virus-infected patients: Characteristics and 1 year prognosis. Eur. Heart J. 32, 41\u201350 (2011).","journal-title":"Eur. Heart J."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/eurheartj\/ehr456","article-title":"Acute coronary syndromes in human immunodeficiency virus patients: A meta-analysis investigating adverse event rates and the role of antiretroviral therapy","volume":"33","author":"D\u2019Ascenzo F.","year":"2012","unstructured":"F. D\u2019Ascenzo, E. Cerrato, G. Biondi-Zoccai, C. Moretti, P. Omed\u00e9, F. Sciuto, M. Bollati, M. G. Modena, F. Gaita, I. Sheiban, Acute coronary syndromes in human immunodeficiency virus patients: A meta-analysis investigating adverse event rates and the role of antiretroviral therapy. Eur. Heart J. 33, 875\u2013880 (2012).","journal-title":"Eur. Heart J."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","article-title":"HIV infection and the risk of acute myocardial infarction","volume":"173","author":"Freiberg M. S.","year":"2013","unstructured":"M. S. Freiberg, C.-C. H. Chang, L. H. Kuller, M. Skanderson, E. Lowy, K. L. Kraemer, A. A. Butt, M. Bidwell Goetz, D. Leaf, K. A. Oursler, D. Rimland, M. Rodriguez Barradas, S. Brown, C. Gibert, K. McGinnis, K. Crothers, J. Sico, H. Crane, A. Warner, S. Gottlieb, J. Gottdiener, R. P. Tracy, M. Budoff, C. Watson, K. A. Armah, D. Doebler, K. Bryant, A. C. Justice, HIV infection and the risk of acute myocardial infarction. JAMA Intern. Med. 173, 614\u2013622 (2013).","journal-title":"JAMA Intern. Med."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu594"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/QAD.0b013e328333ea9e","article-title":"Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men","volume":"24","author":"Lo J.","year":"2010","unstructured":"J. Lo, S. Abbara, L. Shturman, A. Soni, J. Wei, J. A. Rocha-Filho, K. Nasir, S. K. Grinspoon, Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men. AIDS 24, 243\u2013253 (2010).","journal-title":"AIDS"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/QAI.0b013e31828a292c","article-title":"Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: A pilot study","volume":"63","author":"O\u2019Brien M.","year":"2013","unstructured":"M. O\u2019Brien, E. Montenont, L. Hu, M. A. Nardi, V. Valdes, M. Merolla, G. Gettenberg, K. Cavanagh, J. A. Aberg, N. Bhardwaj, J. S. Berger, Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: A pilot study. J. Acquir. Immune Defic. Syndr. 63, 280\u2013288 (2013).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/QAI.0b013e3182439355","article-title":"Increased platelet and microparticle activation in HIV infection: Upregulation of P-selectin and tissue factor expression","volume":"59","author":"Mayne E.","year":"2012","unstructured":"E. Mayne, N. T. Funderburg, S. F. Sieg, R. Asaad, M. Kalinowska, B. Rodriguez, A. H. Schmaier, W. Stevens, M. M. Lederman, Increased platelet and microparticle activation in HIV infection: Upregulation of P-selectin and tissue factor expression. J. Acquir. Immune Defic. Syndr. 59, 340\u2013346 (2012).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/QAD.0000000000000701","article-title":"Activated platelet-T-cell conjugates in peripheral blood of patients with HIV infection: Coupling coagulation\/inflammation and T cells","volume":"29","author":"Green S. A.","year":"2015","unstructured":"S. A. Green, M. Smith, R. B. Hasley, D. Stephany, A. Harned, K. Nagashima, S. Abdullah, S. Pittaluga, T. Imamichi, J. Qin, A. Rupert, A. Ober, H. C. Lane, M. Catalfamo, Activated platelet-T-cell conjugates in peripheral blood of patients with HIV infection: Coupling coagulation\/inflammation and T cells. AIDS 29, 1297\u20131308 (2015).","journal-title":"AIDS"},{"key":"e_1_3_2_11_2","first-page":"1676","article-title":"Platelet reactivity in human immunodeficiency virus infected patients on dual antiplatelet therapy for an acute coronary syndrome: The EVERE2ST-HIV study","volume":"38","author":"Hauguel-Moreau M.","year":"2017","unstructured":"M. Hauguel-Moreau, F. Boccara, A. Boyd, J.-E. Salem, D. Brugier, A. Curjol, J.-S. Hulot, M. Kerneis, S. Galier, A. Cohen, G. Montalescot, J.-P. Collet, J. Silvain, Platelet reactivity in human immunodeficiency virus infected patients on dual antiplatelet therapy for an acute coronary syndrome: The EVERE2ST-HIV study. Eur. Heart J. 38, 1676\u20131686 (2017).","journal-title":"Eur. Heart J."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1160\/th14-03-0269","article-title":"Ticagrelor reduces thrombus formation more than clopidogrel, even when co-administered with bivalirudin","volume":"112","author":"Zafar M. U.","year":"2014","unstructured":"M. U. Zafar, D. A. Vorchheimer, M. P. Tewar, C. Giannarelli, M. Crippa, S. Sartori, D. Rodriguez, U. Baber, R. Mehran, J. J. Badimon, Ticagrelor reduces thrombus formation more than clopidogrel, even when co-administered with bivalirudin. Thromb. Haemost. 112, 1069\u20131070 (2014).","journal-title":"Thromb. Haemost."},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1160\/TH06-04-0188","article-title":"Potent arterial antithrombotic effect of direct factor-Xa inhibition with ZK-807834 administered to coronary artery disease patients","volume":"97","author":"Zafar M. U.","year":"2007","unstructured":"M. U. Zafar, M. E. Farkouh, J. Osende, D. Shimbo, S. Palencia, J. Crook, R. Leadley, V. Fuster, J. H. Chesebro, Potent arterial antithrombotic effect of direct factor-Xa inhibition with ZK-807834 administered to coronary artery disease patients. Thromb. Haemost. 97, 487\u2013492 (2007).","journal-title":"Thromb. Haemost."},{"key":"e_1_3_2_14_2","first-page":"85","article-title":"Hyperreactive platelet phenotypes: Relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulation","volume":"109","author":"Berger J. S.","year":"2013","unstructured":"J. S. Berger, R. C. Becker, C. Kuhn, M. J. Helms, T. L. Ortel, R. Williams, Hyperreactive platelet phenotypes: Relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulation. Thromb. Haemost. 109, 85\u201392 (2013).","journal-title":"Thromb. Haemost."},{"key":"e_1_3_2_15_2","unstructured":"World Health Organization Global Health Observatory data. https:\/\/www.who.int\/gho\/en\/. (Accessed 3-June-2019)."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijid.2016.10.004","article-title":"HIV and aging","volume":"53","author":"Wing E. J.","year":"2016","unstructured":"E. J. Wing, HIV and aging. Int. J. Infect. Dis. 53, 61\u201368 (2016).","journal-title":"Int. J. Infect. Dis."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32835cae9c"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/ije\/dyr164","article-title":"Collaboration of Observational et al., All-cause mortality in treated HIV-infected adults with CD4 \u2265 500\/mm3 compared with the general population: Evidence from a large European observational cohort collaboration","volume":"41","author":"Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord","year":"2012","unstructured":"Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord, C. Lewden, V. Bouteloup, S. De Wit, C. Sabin, A. Mocroft, J. C. Wasmuth, A. van Sighem, O. Kirk, N. Obel, G. Panos, J. Ghosn, F. Dabis, M. Mary-Krause, C. Leport, S. Perez-Hoyos, P. Sobrino-Vegas, C. Stephan, A. Castagna, A. Antinori, A. d\u2019Arminio Monforte, C. Torti, C. Mussini, V. Isern, A. Calmy, R. Teira, M. Egger, J. Grarup, G. Ch\u00eane, Collaboration of Observational et al., All-cause mortality in treated HIV-infected adults with CD4 \u2265 500\/mm3 compared with the general population: Evidence from a large European observational cohort collaboration. Int. J. Epidemiol. 41, 433\u2013445 (2012).","journal-title":"Int. J. Epidemiol."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/infdis\/jiu254","article-title":"Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment","volume":"210","author":"Tenorio A. R.","year":"2014","unstructured":"A. R. Tenorio, Y. Zheng, R. J. Bosch, S. Krishnan, B. Rodriguez, P. W. Hunt, J. Plants, A. Seth, C. C. Wilson, S. G. Deeks, M. M. Lederman, A. L. Landay, Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment. J. Infect. Dis. 210, 1248\u20131259 (2014).","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/hs0102.100531","article-title":"Tumor necrosis factor receptor levels are associated with carotid atherosclerosis","volume":"33","author":"Elkind M. S.","year":"2002","unstructured":"M. S. Elkind, J. Cheng, B. Boden-Albala, T. Rundek, J. Thomas, H. Chen, L. R. E. Rabbani, R. L. Sacco, Tumor necrosis factor receptor levels are associated with carotid atherosclerosis. Stroke 33, 31\u201337 (2002).","journal-title":"Stroke"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/ar4064"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1182\/blood-2005-03-1247","article-title":"Tumor necrosis factor-\u03b1 as trigger of platelet activation in patients with heart failure","volume":"106","author":"Pignatelli P.","year":"2005","unstructured":"P. Pignatelli, L. de Biase, L. Lenti, G. Tocci, A. Brunelli, R. Cangemi, S. Riondino, S. Grego, M. Volpe, F. Violi, Tumor necrosis factor-\u03b1 as trigger of platelet activation in patients with heart failure. Blood 106, 1992\u20131994 (2005).","journal-title":"Blood"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-210179"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"ofw278","DOI":"10.1093\/ofid\/ofw278","article-title":"A randomized placebo controlled trial of aspirin effects on immune activation in chronically human immunodeficiency virus-infected adults on virologically suppressive antiretroviral therapy","volume":"4","author":"O\u2019Brien M. P.","year":"2017","unstructured":"M. P. O\u2019Brien, P. W. Hunt, D. W. Kitch, K. Klingman, J. H. Stein, N. T. Funderburg, J. S. Berger, P. Tebas, B. Clagett, D. Moisi, N. S. Utay, F. Aweeka, J. A. Aberg, A randomized placebo controlled trial of aspirin effects on immune activation in chronically human immunodeficiency virus-infected adults on virologically suppressive antiretroviral therapy. Open Forum Infect. Dis. 4, ofw278 (2017).","journal-title":"Open Forum Infect. Dis."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1160\/TH09-06-0378","article-title":"A new oral antiplatelet agent with potent antithrombotic properties: Comparison of DZ-697b with clopidogrel a randomised phase I study","volume":"103","author":"Zafar M. U.","year":"2010","unstructured":"M. U. Zafar, B. Ib\u00e1\u00f1ez, B. G. Choi, D. A. Vorchheimer, A. Pi\u00f1ero, X. Jin, R. K. Sharma, J. J. Badimon, A new oral antiplatelet agent with potent antithrombotic properties: Comparison of DZ-697b with clopidogrel a randomised phase I study. Thromb. Haemost. 103, 205\u2013212 (2010).","journal-title":"Thromb. Haemost."},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.transci.2009.01.019","article-title":"Thrombelastography","volume":"40","author":"Reikvam H.","year":"2009","unstructured":"H. Reikvam, E. Steien, B. Hauge, K. Liseth, K. G. Hagen, R. St\u00f8rkson, T. Hervig, Thrombelastography. Transfus. Apher. Sci. 40, 119\u2013123 (2009).","journal-title":"Transfus. Apher. Sci."},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1111\/j.1538-7836.2005.01513.x","article-title":"Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography","volume":"3","author":"Rivard G. E.","year":"2005","unstructured":"G. E. Rivard, K. Brummel, K. G. Mann, L. Fan, A. Hofer, E. Cohen, Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography. J. Thromb. Haemost. 3, 2039\u20132043 (2005).","journal-title":"J. Thromb. Haemost."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-05-433946"}],"container-title":["Science Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/sciadv.aav5463","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T18:55:36Z","timestamp":1704826536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/sciadv.aav5463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["10.1126\/sciadv.aav5463"],"URL":"https:\/\/doi.org\/10.1126\/sciadv.aav5463","relation":{},"ISSN":["2375-2548"],"issn-type":[{"value":"2375-2548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6]]},"article-number":"eaav5463"}}